Potential Tumor Suppressive Pathway Involving DUSP6/MKP-3 in Pancreatic Cancer
- 1 June 2003
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 162 (6) , 1807-1815
- https://doi.org/10.1016/s0002-9440(10)64315-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Focus on pancreas cancerCancer Cell, 2002
- Solution Structure of ERK2 Binding Domain of MAPK Phosphatase MKP-3Molecular Cell, 2001
- Nitric Oxide Down-regulates MKP-3 mRNA LevelsJournal of Biological Chemistry, 2000
- Adenovirus-Mediated Inducible Gene Expression through Tetracycline-Controllable Transactivator with Nuclear Localization SignalBiochemical and Biophysical Research Communications, 1997
- MKP-3, a Novel Cytosolic Protein-tyrosine Phosphatase That Exemplifies a New Class of Mitogen-activated Protein Kinase PhosphataseJournal of Biological Chemistry, 1996
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Relationships between DNA Fragmentation, Chromatin Condensation, and Changes in Flow Cytometry Profiles Detected during ApoptosisExperimental Cell Research, 1995
- Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signalingCell, 1995
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesPublished by Elsevier ,1988
- Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs.The Tohoku Journal of Experimental Medicine, 1986